Bryan Herger

478 total citations
11 papers, 410 citations indexed

About

Bryan Herger is a scholar working on Molecular Biology, Hematology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Bryan Herger has authored 11 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hematology and 2 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Bryan Herger's work include Histone Deacetylase Inhibitors Research (7 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Bryan Herger is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Bryan Herger collaborates with scholars based in United States, Japan and Germany. Bryan Herger's co-authors include Warren Fiskus, Kapil N. Bhalla, Rekha Rao, Peter Atadja, Maria E. Balasis, Michael Pranpat, Purva Bali, Yonghua Yang, Aditya Mandawat and Arul M. Chinnaiyan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Bryan Herger

11 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bryan Herger United States	6	334	97	67	50	37	11	410
Zhili Song United States	9	97 0.3×	99 1.0×	88 1.3×	59 1.2×	30 0.8×	17	260
Nicolas Paquet Australia	12	404 1.2×	32 0.3×	69 1.0×	23 0.5×	15 0.4×	24	496
Nancy Hsiung United States	12	256 0.8×	42 0.4×	26 0.4×	27 0.5×	12 0.3×	18	361
Thomas Metz Germany	10	284 0.9×	54 0.6×	128 1.9×	106 2.1×	28 0.8×	22	434
Marion S. Schmidt-Zachmann Germany	14	599 1.8×	70 0.7×	50 0.7×	42 0.8×	32 0.9×	17	678
S G Irving United States	6	203 0.6×	24 0.2×	104 1.6×	210 4.2×	12 0.3×	11	445
Reed Jc United States	8	312 0.9×	21 0.2×	149 2.2×	103 2.1×	139 3.8×	12	483
S.M. Feller United States	3	294 0.9×	108 1.1×	69 1.0×	60 1.2×	46 1.2×	3	410
Sylvia Marecki United States	8	150 0.4×	30 0.3×	140 2.1×	340 6.8×	17 0.5×	9	445
Taiko Inoue-Bungo Japan	5	353 1.1×	99 1.0×	73 1.1×	59 1.2×	22 0.6×	7	441

Countries citing papers authored by Bryan Herger

Since Specialization

Citations

This map shows the geographic impact of Bryan Herger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Herger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Herger more than expected).

Fields of papers citing papers by Bryan Herger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan Herger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Herger. The network helps show where Bryan Herger may publish in the future.

Co-authorship network of co-authors of Bryan Herger

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan Herger. A scholar is included among the top collaborators of Bryan Herger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan Herger. Bryan Herger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Fiskus, Warren, Rekha Rao, Pravina Fernandez, et al.. (2008). Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor–resistant acute myeloid leukemia cells. Blood. 112(7). 2896–2905. 69 indexed citations

Bhalla, Kapil N., et al.. (2007). Anti-leukemia activity of histone deacetylase (HDAC) inhibitor LBH589 involves depletion of EZH2 and DNA methyltransferase (DNMT) 1 through disruption of their chaperone association with heat shock protein (hsp) 90. Journal of Clinical Oncology. 25(18_suppl). 10501–10501. 3 indexed citations

Fiskus, Warren, Rekha Rao, Pravina Fernandez, et al.. (2007). Molecular Characterization and Drug-Sensitivity of Pan Histone Deacetylase Inhibitor Resistant Human Acute Myeloid Leukemia Cells.. Blood. 110(11). 807–807. 1 indexed citations

Fiskus, Warren, Yuan Ren, Purva Bali, et al.. (2007). Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90. Clinical Cancer Research. 13(16). 4882–4890. 122 indexed citations

Herger, Bryan, Warren Fiskus, Rekha Rao, & Kapil N. Bhalla. (2006). Targeting Mutant Nucleophosmin (NPM)1: A Promising Approach To Induce Growth Inhibition and Differentiation in Human AML.. Blood. 108(11). 1905–1905. 1 indexed citations

Fiskus, Warren, Michael Pranpat, Maria E. Balasis, et al.. (2006). Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells. Clinical Cancer Research. 12(19). 5869–5878. 81 indexed citations

Rao, Rekha, Warren Fiskus, Bryan Herger, Peter Atadja, & Kapil N. Bhalla. (2006). Inhibition of Histone Deacetylase (HDAC) 6 and/or Heat Shock Protein (HSP) 90: A Strategy To Abrogate Multi-Level Protective Responses to Misfolded Proteins Induced by Proteasome Inhibitors in Human Leukemia Cells.. Blood. 108(11). 257–257. 1 indexed citations

Fiskus, Warren, Bryan Herger, Rekha Rao, Peter Atadja, & Kapil N. Bhalla. (2006). Hydroxamate Pan-HDAC Inhibitor LBH589 Depletes EZH2 and DNMT1, Partly through hsp90 Inhibition and Its Chaperone Association with DNMT1.. Blood. 108(11). 2233–2233. 1 indexed citations

Fiskus, Warren, Michael Pranpat, Maria E. Balasis, et al.. (2006). Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells. Molecular Cancer Therapeutics. 5(12). 3096–3104. 98 indexed citations

10.

Herger, Bryan, et al.. (2004). The 10 C-terminal residues of HTLV-I protease are not necessary for enzymatic activity. Biochemical and Biophysical Research Communications. 320(4). 1306–1308. 8 indexed citations

11.

Shuker, Suzanne B., et al.. (2003). Understanding HTLV-I Protease. Chemistry & Biology. 10(5). 373–380. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact